Search

everythinglearnresearchcommunity

for

Search:↓

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Minoxidil may protect the brain from damage by preventing cell death and energy loss.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Mushroom compounds may help treat hair loss better than Finasteride.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Tadalafil and Finasteride may help treat aggressive melanoma.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Finasteride sustained-release tablets are stable.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

A mild botulinum toxin injection improved sperm production and movement in aging mice.

Propranolol, flunarizine, and divalproex sodium are equally effective for preventing migraines, but have different side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Apremilast showed mixed results for treating severe alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Ixekizumab effectively treats generalized pustular psoriasis.

An arthritis drug helped a person with severe hair loss regrow their hair.

Suppressing ODC activity reduces tumor growth in hair follicles.

Dutasteride is more effective than finasteride for hair loss treatment.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

The treatment was not recommended due to limited effectiveness and significant side effects.